‘The pharmaceutical industry sees a waiver as a frontal attack on a business model that has served them so well for decades.’ Picture: Getty
Mr Mallee brings up three well-rehearsed and equally well-debunked arguments: his first is that production is not the bottleneck for vaccine coverage; rather, the ability of what he calls “developing countries” to absorb and distribute these vaccines on the ground is the problem.
Secondly, the pandemic has provided ample evidence that geographically diverse pharmaceutical production is not just possible, it is in fact essential to safeguard citizens’ health everywhere. In Europe, for instance, the European Union are currently formulating an entire strategic approach to shorten pharmaceutical supply chains and boost local production as part of their Health Emergency Preparedness and Response Authority deliberations.
ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว
Similar News:คุณยังสามารถอ่านข่าวที่คล้ายกันนี้ซึ่งเรารวบรวมจากแหล่งข่าวอื่น ๆ ได้
แหล่ง: IrishTimesBiz - 🏆 6. / 77 อ่านเพิ่มเติม »